6533b86dfe1ef96bd12ca0f6

RESEARCH PRODUCT

High-density ZnO Nanowires as a Reversible Myogenic-Differentiation-Switch

Cesare GargioliVito ErricoClaudia FuocoErsilia FornettiStefano RufiniChristian FalconiStefano CannataGiovanni SaggioStefano TestaGiuseppe ArrabitoAlessandro Desideri

subject

Myogenic differentiationMaterials scienceCellmuscle differentiation02 engineering and technologyMuscle Development010402 general chemistrySettore BIO/0901 natural sciencesRegenerative medicineZnO nanowireZnO nanowires; mesoangioblasts; muscle differentiation; tissue engineeringTissue engineeringmesoangioblastsMyosinmedicinemesoangioblastGeneral Materials ScienceProgenitor cellNanowiresZno nanowiresSubstrate (chemistry)Cell Differentiation021001 nanoscience & nanotechnology0104 chemical sciencesCell biologymedicine.anatomical_structuretissue engineeringZnO nanowiresZinc Oxide0210 nano-technology

description

Mesoangioblasts are outstanding candidates for stem-cell therapy and are already being explored in clinical trials. However, a crucial challenge in regenerative medicine is the limited availability of undifferentiated myogenic progenitor cells because growth is typically accompanied by differentiation. Here reversible myogenic-differentiation switching during proliferation is achieved by functionalizing the glass substrate with high-density ZnO nanowires (NWs). Specifically, mesoangioblasts grown on ZnO NWs present a spherical viable undifferentiated cell state without lamellopodia formation during the entire observation time (8 days). Consistently, the myosin heavy chain, typically expressed in skeletal muscle tissue and differentiated myogenic progenitors, is completely absent. Remarkably, NWs do not induce any damage while they reversibly block differentiation, so that the differentiation capabilities are completely recovered upon cell removal from the NW-functionalized substrate and replating on standard culture glass. This is the first evidence of a reversible myogenic-differentiation switch that does not affect the viability. These results can be the first step toward for the in vitro growth of a large number of undifferentiated stem/progenitor cells and therefore can represent a breakthrough for cell-based therapy and tissue engineering.

10.1021/acsami.7b19758http://hdl.handle.net/10447/287134